apopain inhibitors (Merck Sharp & Dohme)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameapopain inhibitors (Merck Sharp & Dohme)
Drug Alias Nameapopain inhibitors (MSD)CPP32 inhibitor (Merck)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCaspase-3 inhibitors
TargetsCaspase-3
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Ltd
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A